FEB 13, 2017 1:54 PM PST

Females More Prone to Disease Due to Key Immunological Difference

WRITTEN BY: Kara Marker

There seems to be a key genetic difference between males and females that is not related to sex chromosomes. Instead, it is a difference in activity between the two sexes in a specific type of immune cell which leaves females more vulnerable to some stress-related and allergic diseases.

The immune cell found in this study to put females at an increased risk for certain diseases is the mast cell. These immune components usually do not circulate in the bloodstream the way other immune cells do. Instead, they exist in tissue types all over the body fulfilling a plethora of roles such as vasodilation, angiogenesis, pathogen elimination, and even maintenance of other immune cells.

From Michigan State University, in a new study published in the journal Biology of Sex Differences, researchers picked apart and examined several genes within the RNA genome. "Over 8,000 differentially expressed genes were found in female mast cells compared to male mast cells," said lead researcher and associate professor Adam Moeser said. "While male and female mast cells have the same sets of genes on their chromosomes, with the exception of the XY sex chromosomes, the way the genes act vary immensely between the sexes."

Specifically, they saw an increase in inflammatory activity linked to mast cells in females that causes a more intense immune response to stress and allergy, resulting in diseases like irritable bowel syndrome (IBS). Doctors aren’t sure what causes IBS, but the associated symptoms seem to be consistent: abdominal pain and discomfort, changes in bowel movements, and bloating.

With this research completed, transitioning to sex-specific treatments that directly target mast cells in females specifically is definitely something that will be considered. The next question Moeser and his team will have to answer though is this: at what point to mast cells begin to act differently between males and females?

“Pinpointing when this variance happens will let us know if it occurs during adulthood or in individuals at an early age," Moeser said. "Many mast cell diseases exhibit a sex bias in children and if we can identify the timing and the mechanism of what's influencing the change, we'll have an even better understanding of how these immune cells cause disease and know when to intervene with potentially new therapies."

Sources: Michigan State University, Frontiers in Immunology, National Institute of Diabetes and Digestive and Kidney Diseases

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 15, 2019
Immunology
SEP 15, 2019
New Observations of a Cancer Transcriptase
New research shows a transcriptase that helps time cell death varies in expression, and is unusually localized, in cancer cells.  The transcriptase, T...
NOV 01, 2019
Immunology
NOV 01, 2019
Immunity to HPV Can Prevent Skin Cancer
Scientists discovered a surprise benefit of low-risk human papillomaviruses (HPV), a typical resident of human skin. New research shows that these harmless...
NOV 13, 2019
Health & Medicine
NOV 13, 2019
Antibiotic Resistance by the Numbers
The Centers for Disease Control and Prevention (CDC) just released its latest Antibiotic Threats in the United States report, which is summarized in the vi...
NOV 20, 2019
Immunology
NOV 20, 2019
Harnessing the Power of Natural Killer Cells to Fight Cancer
Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results invest...
FEB 14, 2020
Immunology
FEB 14, 2020
Rewired natural killer cells show promising results in leukemia patients
Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrating host-rejection responses agains...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
Loading Comments...